[1]
R. Helou and M. Rhalimi, “CHOLINESTERASE INHIBITORS AND THE RISK OF PULMONARY DISORDERS IN HOSPITALIZED DEMENTIA PATIENTS”, J Popl Ther Clin Pharmacol, vol. 17, no. 3, Dec. 2018, Accessed: Sep. 20, 2025. [Online]. Available: https://www.jptcp.com/index.php/jptcp/article/view/507